Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foundation Venture Capital Group (FVCG) is a specialized venture capital firm and a subsidiary of the New Jersey Health Foundation (NJHF). The firm focuses on providing pre-seed and seed-stage funding to start-up companies developing innovative health-related technologies, particularly those originating from New Jersey’s academic and research institutions. FVCG provides not only capital but also management expertise and strategic guidance to help bridge the gap between laboratory discovery and commercial viability. Its portfolio includes a diverse range of companies in the biotechnology, medical device, and diagnostic sectors, often collaborating with institutions such as Rutgers University and Rowan University.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foundation Ventures.